Last updated: October 25, 2022
Sponsor: The University of Texas Health Science Center, Houston
Overall Status: Active - Recruiting
Phase
N/A
Condition
Epilepsy (Pediatric)
Treatment
N/AClinical Study ID
NCT05600738
HSC-MS-22-0045
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- diagnosis of Epilepsy
- undergoing neuromodulation therapy with clinically implanted neuromodulation devices (DBS, RNS)
- followed in the outpatient epilepsy clinic
Exclusion
Exclusion Criteria:
- pregnant women
- active psychosis, major depression, or suicidal ideation in the preceding year
- Intelligence quotient (IQ) less than 70 as measured by clinical neuropsychologicalevaluation
- Do not agree to share their medical records for research purposes
Study Design
Total Participants: 25
Study Start date:
August 26, 2022
Estimated Completion Date:
December 31, 2027
Connect with a study center
The University of Texas Health Science Center at Houston
Houston, Texas 77030
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.